Table 1.
Clinicopathologic features | Total number of patients, n=86 | Number of patients
|
P | |
---|---|---|---|---|
Low miR-212 | High miR-212 | |||
Age (years) | ||||
<50 | 27 | 14 | 13 | 0.816 |
≥50 | 59 | 29 | 30 | |
Sex | ||||
Male | 69 | 36 | 33 | 0.417 |
Female | 17 | 7 | 10 | |
HBV | ||||
Absent | 30 | 17 | 13 | 0.365 |
Present | 56 | 26 | 30 | |
Serum AFP level (ng/mL) | ||||
<400 | 34 | 11 | 23 | 0.008* |
≥400 | 52 | 32 | 20 | |
Tumor size (cm) | ||||
<5 | 30 | 9 | 21 | 0.007* |
≥5 | 56 | 34 | 22 | |
Number of tumor nodules | ||||
1 | 66 | 31 | 35 | 0.307 |
≥2 | 20 | 12 | 8 | |
Cirrhosis | ||||
Absent | 37 | 20 | 17 | 0.514 |
Present | 49 | 23 | 26 | |
Venous infiltration | ||||
Absent | 42 | 19 | 23 | 0.388 |
Present | 44 | 24 | 20 | |
Edmondson-Steiner grading | ||||
I+II | 49 | 19 | 30 | 0.017* |
III+IV | 37 | 24 | 13 | |
TNM tumor stage | ||||
I+II | 61 | 25 | 36 | 0.009* |
III+IV | 25 | 18 | 7 |
Note:
Statistically significant.
Abbreviations: AFP, alpha fetoprotein; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; miR-212, microRNA 212; TNM, tumor-node-metastasis.